Comparing Cybin (NYSE:CYBN) & PepGen (NASDAQ:PEPG)
PepGen (NASDAQ:PEPG – Get Free Report) and Cybin (NYSE:CYBN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Volatility and Risk PepGen has a beta of 1.69, indicating […]
More Stories
Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) Price Target at $35.40
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research...
Analysts Set Spirax-Sarco Engineering plc (LON:SPX) Price Target at GBX 9,158
Spirax-Sarco Engineering plc (LON:SPX – Get Free Report) has been given an average rating of “Reduce” by the eight ratings...
Markel Group Inc. (NYSE:MKL) Receives $1,626.83 Average Target Price from Analysts
Markel Group Inc. (NYSE:MKL – Get Free Report) has been assigned an average recommendation of “Hold” from the six brokerages...
UWM Holdings Co. (NYSE:UWMC) Given Consensus Rating of “Reduce” by Analysts
UWM Holdings Co. (NYSE:UWMC – Get Free Report) has been given a consensus recommendation of “Reduce” by the seven research...
Endava plc (NYSE:DAVA) Given Average Rating of “Moderate Buy” by Brokerages
Endava plc (NYSE:DAVA – Get Free Report) has received an average rating of “Moderate Buy” from the ten ratings firms...
RE/MAX Holdings, Inc. (NYSE:RMAX) Receives $11.90 Consensus Target Price from Brokerages
Shares of RE/MAX Holdings, Inc. (NYSE:RMAX – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the...